about
Non-pharmacological interventions for cognitive impairment due to systemic cancer treatmentDrugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohortsLow-dose aspirin and survival from lung cancer: a population-based cohort studyStatin use and breast cancer survival: a nationwide cohort study in Scotland.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review.Commonly used medications and endometrial cancer survival: a population-based cohort study.Metformin use and survival after colorectal cancer: A population-based cohort study.Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.Statin use and survival from lung cancer: a population-based cohort study.Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.Do smoking and alcohol behaviours influence GI cancer survival?Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review.Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK BiobankVitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort studyModel for Identifying Individuals at Risk for Esophageal AdenocarcinomaHigh PTGS2 expression in post neoadjuvant chemotherapy treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort studySex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort studyProton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studiesThe Risk of Cardiovascular Disease in Prostate Cancer Patients Receiving Androgen Deprivation TherapiesFurosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort studyThe association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort studyThe role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control studyInformation on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk FactorsReal-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databasesStatin use and risk of liver cancer: Evidence from two population-based studiesConcurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis
P50
Q26470426-6D9EA9FA-1236-4326-8DBD-22A321E3F168Q35093193-498F526B-73E7-41BD-A904-7E9FFCC22544Q35843033-E7F6D477-2D39-44F1-A1D0-880732E98E43Q36095264-322E5AD4-6CD2-4621-BE85-7F540B065B16Q37960818-39FAE2A7-E49F-408E-9B3A-34484DF684CAQ38118003-7A96E93D-7D35-4D39-B96B-C0A4F5E20581Q40132826-ED440055-E08F-4585-806E-E860D9C0AE56Q40583003-97AD39AF-5DE6-4634-8574-4DE387DE549EQ40938507-D46492A1-E9BF-444D-A755-B44C42F83A7BQ40985401-B8658157-53E5-44E2-B3D1-0BF5355E052DQ47127277-8A42FAAE-3E83-4821-B7A1-B9A9BBEF91D5Q47626689-B03DEECA-8079-47B6-8F7F-8D8FE85D8274Q48111463-8CD4FD08-8E6F-4625-8733-01F62E907395Q48874889-BBEA9934-9544-4AEA-B414-AC063F0C917AQ49362106-03A1D378-2D33-4F3A-9D9F-5193EFFF245EQ49494443-CF669A22-0824-4AF9-8288-19BE3A4BD11CQ52658906-E4E5C644-9693-4EAE-A1C8-BB9E08F78DF7Q57063298-8319A9B1-5563-4330-83F9-0759F00A0FABQ57821057-DC90256F-1186-4BB3-89E1-158CA48EC0CBQ58204399-0C407875-704A-4AB2-B122-43485067FAF9Q58580706-F312C5A1-6001-43AA-A4CC-714735F36EC0Q59137519-4C45BE85-3DF3-4472-9904-AB45EAD561FEQ88612679-D43171D6-396C-48A7-B819-8CFD28B84AC0Q90940158-95FCA83B-983B-4EBA-B131-92D48FD07E4BQ91004523-D4656571-3D2D-4024-AD50-8CD35A26616BQ91176537-2A151B09-FB71-4CCB-A125-4043E8AA202FQ91241275-BC9DE03B-1686-4A4E-AE93-0658B4EB3305Q91651559-968681C9-86C5-475E-A0BD-427D292EA030Q91676427-ED71F194-A809-457F-B667-25E48EFEC070Q92186644-2EB2109C-514D-4503-A9D3-8110E75654E4Q94445744-38AB78FF-9522-4789-BC50-7831860A6806
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Úna C Mc Menamin
@en
Úna C Mc Menamin
@nl
type
label
Úna C Mc Menamin
@en
Úna C Mc Menamin
@nl
prefLabel
Úna C Mc Menamin
@en
Úna C Mc Menamin
@nl
P31
P496
0000-0002-6391-8893